- Home
- HRMY vs CABO Comparison
HRMY vs CABO Comparison
Compare HRMY & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- CABO
- Stock Information
- Founded
- HRMY 2017
- CABO 1980
- Country
- HRMY United States
- CABO United States
- Employees
- HRMY N/A
- CABO N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- CABO Cable & Other Pay Television Services
- Sector
- HRMY Health Care
- CABO Telecommunications
- Exchange
- HRMY Nasdaq
- CABO Nasdaq
- Market Cap
- HRMY 2.1B
- CABO 748.3M
- IPO Year
- HRMY 2020
- CABO N/A
- Fundamental
- Price
- HRMY $32.39
- CABO $172.03
- Analyst Decision
- HRMY Strong Buy
- CABO Hold
- Analyst Count
- HRMY 9
- CABO 3
- Target Price
- HRMY $55.33
- CABO $171.00
- AVG Volume (30 Days)
- HRMY 668.4K
- CABO 125.0K
- Earning Date
- HRMY 10-28-2025
- CABO 11-06-2025
- Dividend Yield
- HRMY N/A
- CABO 3.43%
- EPS Growth
- HRMY 58.41
- CABO N/A
- EPS
- HRMY 3.10
- CABO N/A
- Revenue
- HRMY $772,527,000.00
- CABO $1,542,441,000.00
- Revenue This Year
- HRMY $20.09
- CABO N/A
- Revenue Next Year
- HRMY $16.74
- CABO N/A
- P/E Ratio
- HRMY $10.46
- CABO N/A
- Revenue Growth
- HRMY 17.74
- CABO N/A
- 52 Week Low
- HRMY $26.47
- CABO $117.54
- 52 Week High
- HRMY $41.61
- CABO $437.00
- Technical
- Relative Strength Index (RSI)
- HRMY 30.32
- CABO 60.98
- Support Level
- HRMY $32.87
- CABO $156.35
- Resistance Level
- HRMY $37.05
- CABO $169.00
- Average True Range (ATR)
- HRMY 1.15
- CABO 7.52
- MACD
- HRMY -0.60
- CABO 0.71
- Stochastic Oscillator
- HRMY 1.59
- CABO 73.52
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.